Jm. Pash et E. Canalis, TRANSCRIPTIONAL REGULATION OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-5 BY PROSTAGLANDIN E(2) IN OSTEOBLAST CELLS, Endocrinology, 137(6), 1996, pp. 2375-2382
Insulin-like growth factor (IGF)-binding protein-5 (IGFBP-5) is an aut
ocrine and paracrine factor that modulates the effects of IGFs. We exa
mined the mechanisms that regulate IGFBP-5 synthesis by PGE(2) in oste
oblast-enriched cells from fetal rat calvaria (Oh cells). PGE(2) at 1
mu M for 2-8 h increased IGFBP-5 heterogeneous nuclear RNA levels and
did not change the half-life of IGFBP-5 messenger RNA in Ob cells, sug
gesting that PGE(2) stimulates IGFBP-5 transcription. To analyze the e
lements responsible for this effect, regions of the mouse IGFBP-5 prom
oter from -2695 to +120 bp were ligated into pGL-2-basic and transient
ly transfected into Ob cells. PGE(2) caused a time- and dose-dependent
increase in IGFBP-5 promoter activity. Further analysis revealed two
potential PGE(2)-responsive regions in the -2695 to -1470 and the -989
to -332 fragments. The effect of PGE(2) on IGFBP-5 messenger RNA and
heterogeneous nuclear RNA levels was mimicked by forskolin and inhibit
ed by the PKA inhibitor H-89, suggesting that part of the PGE(2) effec
t was mediated through a cAMP-dependent pathway. H-89 also blocked bas
al and PGE(2)-stimulated IGFBP-5 promoter activities. We conclude that
PGE(2) regulates IGFBP-5 synthesis in Ob cells by transcriptional mec
hanisms. PKA-dependent pathways account for part of the effect of PGE(
2) on IGFBP-5 expression. Deletion analysis of the IGFBP-5 promoter su
ggests the presence of two PGE(2)-responsive regions.